{"entity":{"type":"insider","cik":"0001591100","url":"/insider/0001591100","json_url":"/insider/0001591100.json","name":"Loewen Andrea","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":4,"first":"2023-03-06","last":"2023-09-18","span_basis":"filed_date"},"name_variants":[{"name":"Loewen Andrea","source":"filing","n_filings":4,"first_seen":"2023-03-06","last_seen":"2023-09-18"}],"transactions":[{"id":8116760,"accession":"0001209191-23-049792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049792","line_url":"/filing/0001209191-23-049792#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3175.0,"shares_display":"3,175","price_per_share":172.0254,"price_display":"172.03","price_state":"stated","total_value":546180.645,"total_display":"546,180.64","total_whole":"546,181","shares_owned_after":28416.0,"shares_owned_after_display":"28,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":7922070,"accession":"0001209191-23-029791","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-029791","line_url":"/filing/0001209191-23-029791#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313.0,"shares_display":"313","price_per_share":81.02,"price_display":"81.02","price_state":"stated","total_value":25359.26,"total_display":"25,359.26","total_whole":"25,359","shares_owned_after":31591.0,"shares_owned_after_display":"31,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-16","scope":"insider"},{"id":7922067,"accession":"0001209191-23-029791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-029791","line_url":"/filing/0001209191-23-029791#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103.0,"shares_display":"103","price_per_share":84.71,"price_display":"84.71","price_state":"stated","total_value":8725.13,"total_display":"8,725.13","total_whole":"8,725","shares_owned_after":31904.0,"shares_owned_after_display":"31,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-16","scope":"insider"},{"id":7922064,"accession":"0001209191-23-029791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029791","line_url":"/filing/0001209191-23-029791#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":86.2618,"price_display":"86.26","price_state":"stated","total_value":582267.15,"total_display":"582,267.15","total_whole":"582,267","shares_owned_after":32007.0,"shares_owned_after_display":"32,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-16","scope":"insider"},{"id":8392505,"accession":"0001209191-23-017553","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-017553","line_url":"/filing/0001209191-23-017553","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19036.0,"shares_display":"19,036","price_per_share":83.42808152973313,"price_display":"83.43","price_state":"stated","total_value":1588136.96,"total_display":"1,588,136.96","total_whole":"1,588,137","shares_owned_after":39957.0,"shares_owned_after_display":"39,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-09","scope":"insider","n_lines":2},{"id":7968073,"accession":"0001209191-23-016327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-016327","line_url":"/filing/0001209191-23-016327#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1601.0,"shares_display":"1,601","price_per_share":87.73,"price_display":"87.73","price_state":"stated","total_value":140455.73,"total_display":"140,455.73","total_whole":"140,456","shares_owned_after":42793.0,"shares_owned_after_display":"42,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":7968070,"accession":"0001209191-23-016327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016327","line_url":"/filing/0001209191-23-016327#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001591100","owner_name":"Loewen Andrea","owner_display_name":"Loewen Andrea","owner_url":"/insider/0001591100","role":"Officer (SVP, Global Regulatory Affairs)","role_mark":"O","role_mark_label":"Officer (SVP, Global Regulatory Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Global Regulatory Affairs","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":218.0,"shares_display":"218","price_per_share":90.61,"price_display":"90.61","price_state":"stated","total_value":19752.98,"total_display":"19,752.98","total_whole":"19,753","shares_owned_after":44394.0,"shares_owned_after_display":"44,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (SVP, Global Regulatory Affairs)","n_filings":4,"first_seen":"2023-03-06","last_seen":"2023-09-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591100","retrieved_at":"2026-08-27T06:59:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}